These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2571197)

  • 1. A deficiency in A alpha chain's N-terminal alanine residue as a major cause of the slow coagulation of fetal fibrinogen.
    Hasegawa N; Sasaki S
    Thromb Res; 1989 Jun; 54(6):595-602. PubMed ID: 2571197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of acid-base balance and Apgar score on fibrinopeptide A and fibrinopeptide B beta 15-42 in umbilical cord blood].
    Ogura H; Adachi H; Takeda T; Nakagomi H; Kanno S; Yokoyama M; Kinoshita T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):128-34. PubMed ID: 3102647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Seattle releases half the normal amount of fibrinopeptide B.
    Branson HE; Schmer G; Theodor I; Pirkle H
    Acta Haematol; 1983; 70(4):257-63. PubMed ID: 6414212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique pattern of fibrinogen cleavage by human leukocyte proteases.
    Bilezikian SB; Nossel HL
    Blood; 1977 Jul; 50(1):21-8. PubMed ID: 871524
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
    Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
    Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fraction of high molecular weight (HMW) fibrinogen and phosphorylated fibrinopeptide A in fetal fibrinogen.
    Seydewitz HH; Witt I
    Thromb Res; 1989 Sep; 55(6):785-90. PubMed ID: 2781536
    [No Abstract]   [Full Text] [Related]  

  • 8. Conservation of human fibrinogen conformation after cleavage of the B beta chain NH2 terminus.
    Pandya BV; Cierniewski CS; Budzynski AZ
    J Biol Chem; 1985 Mar; 260(5):2994-3000. PubMed ID: 2579073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
    Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: investigation of nine congenital fibrinogen abnormalities.
    Southan C; Thompson E; Lane DA
    Br J Haematol; 1987 Apr; 65(4):469-73. PubMed ID: 3580304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of human fibrinopeptides by high-performance liquid chromatography.
    Kehl M; Lottspeich F; Henschen A
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An abnormal fibrinogen with delayed fibrinopeptide A release.
    Lane DA; VanRoss M; Kakkar VV; Bottomley KJ; Dhir K; Holt LP; MacIver JE
    Br J Haematol; 1980 Sep; 46(1):89-98. PubMed ID: 7426452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative N-terminal analysis of fibrinogen-fibrin-related antigen [FR antigen] from human plasma.
    Harris JU; Johnson AJ; Merskey C; Wang MT; Robinson D
    Biochem J; 1979 Dec; 183(3):623-32. PubMed ID: 540036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution NMR studies of fibrinogen-like peptides in solution: resonance assignments and conformational analysis of residues 1-23 of the A alpha chain of human fibrinogen.
    Ni F; Scheraga HA; Lord ST
    Biochemistry; 1988 Jun; 27(12):4481-91. PubMed ID: 3166991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
    Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
    Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid sequences of lamprey fibrinopeptides A and B and characterizations of the junctions split by lamprey and mammalian thrombins.
    Cottrell BA; Doolittle RF
    Biochim Biophys Acta; 1976 Dec; 453(2):426-38. PubMed ID: 999898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine leads to histidine substitution.
    Southan C; Kehl M; Henschen A; Lane DA
    Br J Haematol; 1983 May; 54(1):143-51. PubMed ID: 6849832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
    Schreiber WE; Schmer G
    Thromb Res; 1985 Jan; 37(1):45-52. PubMed ID: 3983901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.